Reports for BAUSCH HEALTH, CANADA INC.
Company Name
BAUSCH HEALTH, CANADA INC.
Totals |
||
Shortage reports |
346 |
|
| Actual shortage: | 11 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 34 (10%) | |
| Resolved: | 301 (87%) | |
Discontinuation Reports |
13 |
|
| To be discontinued: | 1 (8%) | |
| Discontinued: | 12 (92%) | |
| Reversed: | 0 (0%) | |
Late reports |
96 (27%) |
|
Overdue reports |
1 (8%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| XERESE | 1% 5% | CREAM | Avoided shortage | 2023-02-08 | 2023-04-11 | 183894 |
| ROFACT | 300MG | CAPSULE | Avoided shortage | 2023-03-13 | 2023-03-27 | 186883 |
| QVAR | 100MCG | METERED-DOSE AEROSOL | Resolved | 2022-12-07 | 2023-03-23 | 177248 |
| CUPRIMINE | 250MG | CAPSULE | Avoided shortage | 2023-03-13 | 2023-03-23 | 186886 |
| BENZACLIN | 5% 1% | GEL | Avoided shortage | 2022-12-21 | 2023-03-23 | 179119 |
| LODALIS | 625MG | TABLET | Resolved | 2023-01-11 | 2023-03-04 | 180700 |
| LOPROX | 1% | LOTION | Resolved | 2022-12-21 | 2023-03-03 | 179123 |
| ROFACT | 300MG | CAPSULE | Resolved | 2022-12-02 | 2023-02-24 | 176953 |
| ROFACT | 150MG | CAPSULE | Resolved | 2022-12-07 | 2023-02-24 | 177254 |
| NIDAGEL | 0.75% | GEL | Resolved | 2022-11-09 | 2023-01-25 | 174138 |
| RALIVIA | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-12-07 | 2023-01-11 | 177241 |
| MANERIX | 150MG | TABLET | Resolved | 2022-12-21 | 2023-01-04 | 179114 |
| DELATESTRYL | 200MG | SOLUTION | Resolved | 2022-12-02 | 2022-12-21 | 176956 |
| LOPROX | 1% | CREAM | Resolved | 2022-09-12 | 2022-12-07 | 169138 |
| LOPROX | 1% | LOTION | Resolved | 2022-11-09 | 2022-12-02 | 174144 |
| DIASTAT | 5MG | GEL | Resolved | 2022-04-21 | 2022-11-23 | 159254 |
| RETIN-A | 0.025% | GEL | Resolved | 2022-09-23 | 2022-09-28 | 170140 |
| VIRAZOLE | 6G | POWDER FOR SOLUTION AEROSOL | Resolved | 2022-02-17 | 2022-09-27 | 155206 |
| NORITATE | 1% | CREAM | Resolved | 2022-08-25 | 2022-09-27 | 167954 |
| WELLBUTRIN XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-07-20 | 2022-09-23 | 165044 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DELATESTRYL | 200MG | SOLUTION | Discontinued | 2024-03-11 | 2024-04-26 | 221772 |
| LODALIS | 3.75G | POWDER FOR SUSPENSION | Discontinued | 2023-12-08 | 2024-02-20 | 212799 |
| VITAMIN A ACID | 0.05% | GEL | Discontinued | 2024-01-30 | 2024-02-08 | 217843 |
| VITAMIN A ACID | 0.025% | GEL | Discontinued | 2024-01-30 | 2024-02-08 | 217848 |
| VITAMIN A ACID | 0.01% | GEL | To be discontinued | 2024-01-30 | 2024-01-30 | 217835 |
| ALTACE HCT | 12.5MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214014 |
| ALTACE HCT | 12.5MG 2.5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214011 |
| ALTACE HCT | 25MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214027 |
| ALTACE HCT | 12.5MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214024 |
| ALTACE HCT | 25MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214017 |
| LIDEX | 0.05% | CREAM | Discontinued | 2023-12-08 | 2023-12-08 | 212804 |
| AIROMIR | 100MCG | METERED-DOSE AEROSOL | Discontinued | 2023-11-29 | 2023-11-29 | 211859 |
| THEOLAIR | 80MG | SOLUTION | Discontinued | 2021-04-26 | 2021-04-27 | 138081 |
Showing 1 to 13 of 13